Scholarlink

<p>The ADVANCE cohort study is a prospective cohort study investigating the impact of sustaining a serious physical combat injury whilst on deployment to Afghanistan on long-term health outcomes. The cohort will provide essential data on medical/psychosocial risk factors and outcomes associated with combat injury and establish injury-specific mechanisms of disease. Participants include UK Armed Forces personnel who sustained serious physical combat injuries and a frequency-matched comparison group who sustained no such injuries (uninjured group). The cohort consists of 1145 participants, with a baseline response rate of 59.6% for the injured group (<i>n</i> = 579) and 56.3% for the uninjured group (<i>n</i> = 566). The first follow up of this cohort retained 92% of the sample (<i>n</i> = 1053/1145). This cohort profile describes the baseline and first follow up demographics for ADVANCE, as well as details on published research projects spanning military epidemiology, physical health, including cardiovascular, respiratory, musculoskeletal and neurological, mental health and health-related behaviours. These projects comprise identification of early risk factors for disease and observed differences in health-characteristics between groups. Since baseline assessment of the cohort, ADVANCE has expanded investigations across physical and mental health domains, utilising advice from participant engagement and an international scientific advisory group. Researchers working on the ADVANCE cohort continue to engage with policy makers, clinicians and participants to ensure a wide-ranging impact from work conducted.</p><p><i>Registration</i>: The ADVANCE Study is registered at ISRCTN ID: ISRCTN57285353.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Evaluating the physical and psychosocial impact of serious physical combat injuries in UK armed forces personnel-the ADVANCE cohort study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年9月24日

查看全文
  • Daniel Dyball,
  • Susie Schofield,
  • Howard Burdett,
  • Christopher J. Boos,
  • Anthony M. J. Bull,
  • Paul Cullinan,
  • Nicola T. Fear,
  • Alexander N. Bennett,
  • Helen Blackman,
  • Grace Blissitt,
  • Melanie Chesnokov,
  • Emma Coady,
  • Sarah Evans,
  • Guy Fraser,
  • Nicola Goodman,
  • Alison Hever,
  • Meliha Kaya-Barge,
  • Jocelyn Keshet-Price,
  • Maija Maskuniitty,
  • Eleanor Miller,
  • Steven Parkes,
  • Bharti Patel,
  • Samatha Paul,
  • David Pernet,
  • Vlad Pop,
  • Helen Prentice,
  • Urszula Pucilowska,
  • Stefan Sprinkmoller,
  • Jodie Stevenson,
  • Lalji Varsani,
  • Anna Verey,
  • Molly Waldron,
  • Owen Walker,
  • Danny Weston,
  • Tasarla White,
  • Seamus Wilson

摘要

The ADVANCE cohort study is a prospective cohort study investigating the impact of sustaining a serious physical combat injury whilst on deployment to Afghanistan on long-term health outcomes. The cohort will provide essential data on medical/psychosocial risk factors and outcomes associated with combat injury and establish injury-specific mechanisms of disease. Participants include UK Armed Forces personnel who sustained serious physical combat injuries and a frequency-matched comparison group who sustained no such injuries (uninjured group). The cohort consists of 1145 participants, with a baseline response rate of 59.6% for the injured group (n = 579) and 56.3% for the uninjured group (n = 566). The first follow up of this cohort retained 92% of the sample (n = 1053/1145). This cohort profile describes the baseline and first follow up demographics for ADVANCE, as well as details on published research projects spanning military epidemiology, physical health, including cardiovascular, respiratory, musculoskeletal and neurological, mental health and health-related behaviours. These projects comprise identification of early risk factors for disease and observed differences in health-characteristics between groups. Since baseline assessment of the cohort, ADVANCE has expanded investigations across physical and mental health domains, utilising advice from participant engagement and an international scientific advisory group. Researchers working on the ADVANCE cohort continue to engage with policy makers, clinicians and participants to ensure a wide-ranging impact from work conducted.

Registration: The ADVANCE Study is registered at ISRCTN ID: ISRCTN57285353.